Immunoprecise Antibodies (IPA.V) subsidiary, IPA Europe, invested in its B-Cell Select platform at its research division in Oss, the Netherlands, enabled by prior investments in equipment to automate and…
Pharmaceuticals
Normally when we we write about Revive Therapeutics (RVV.C), it’s generally to provide an update on their progress regarding their experimental COVID-19 palliative, Bucillamine. This update isn’t that, and…
Doing what we do at Equity Guru, every day, we receive emails and dms from shareholders of different companies – all expressing their grievances. Disgruntled with various issues such…
Over twenty million people worldwide have contracted COVID-19. Of those 12.4 million have recovered and approximately 738,000 have died at the time of writing, according to Johns Hopkins University…
Red Light Holland (TRIP.C) has fast-tracked its 3,000 square-foot custom-built indoor production and distribution facility in Horst, the Netherlands, and is now growing its first crop of magic truffles,…
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”….
Mydecine Innovations Group’s (MYCO.C) subsidiary Mindleap Health expanded its digital therapeutic services, dealing specifically with addiction, by adding three new programs to its platform. This company is no stranger…
Formerly dismissed-by-many pharmaceutical company Revive Therapeutics (RVV.C) jumped a whopping 68% Friday upon revealing it has been granted approval to move forward with phase 3 clinical trials on the…
If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should be making over 38%…
War is a part of human nature. It’s the greatest driver of human innovation, and if we’re inclined to be cynical we could state that it’s the key reason…